Research Article
Transdermal Nitroglycerin Delivery Using Acrylic Matrices: Design, Formulation, and In Vitro Characterization
Table 3
Various transdermal DIAPs nitroglycerin formulations.
| | Compound | TNG-10M-101 | TNG-10M-102 | TNG-10M-103 | TNG-10M-104 | TNG-10M-105 | TNG-10M-106 | TNG-10M-107 | TNG-10M-108 | TNG-10M-109 | TNG-10M-110 | TNG-10M-111 | TNG-10M-112 |
| | Nitroglycerin (mL) | 4 | 4 | 4 | 3.9 | 3.9 | 3.9 | 3.9 | 3.9 | 2.6 | 2.6 | 2.6 | 2.6 | | Duro-Tak 2054 (gr) | 5.4 | — | — | 4.7 | 4.7 | 4.7 | — | — | — | — | 2.5 | 2.5 | | Duro-Tak 2051 (gr) | — | 5.4 | — | — | — | — | — | — | — | — | — | — | | Duro-Tak 2516 (gr) | — | — | 5.4 | — | — | — | 4.7 | 4.7 | 2.5 | 2.5 | — | — | | Cetyl Alcohol (gr) | — | — | — | 0.3 | — | — | — | — | — | — | — | — | | Oleic Acid (gr) | — | — | — | — | 0.3 | — | 0.3 | — | — | — | — | — | | PG (gr) | — | — | — | — | — | 0.3 | — | 0.3 | — | 0.19 | — | 0.19 |
|
|
